Cross Country Healthcare INC

Cross Country Healthcare's stockholders have overwhelmingly approved the merger agreement with KL Criss Cross Intermediate, LLC, paving the way for the company to be delisted from NASDAQ.

Cross Country Healthcare, Inc. files an 8-K to supplement its proxy statement regarding a pending merger, addressing shareholder litigation and providing updated financial analysis details.

Cross Country Healthcare announced first quarter 2026 financial results, reporting a net loss but highlighting sequential revenue growth and strategic wins.

Cross Country Healthcare, Inc. announced a definitive agreement to be acquired by Knox Lane in an all-cash transaction valued at $437 million, offering a significant premium to its shareholders.

Cross Country Healthcare, Inc. has scheduled its first quarter 2026 earnings conference call for May 7, 2026.

Cross Country Healthcare appoints Amiee Hawkins as Chief Operating Officer effective March 28, 2026, with no changes to her compensation.

Cross Country Healthcare, Inc. reported a net loss of $4.3 million for Q1 2026, with revenues down 17.8% year-over-year, alongside the announcement of a definitive merger agreement.

Cross Country Healthcare reported a significant net loss and revenue decline in Q3 2025, primarily due to volume decreases in staffing segments, while its merger with Aya Healthcare faces delays from a government shutdown.

Cross Country Healthcare, Inc. reported a net loss of $6.7 million in Q2 2025, a significant improvement from the prior year, despite a 19.3% revenue decline, as it progresses towards its acquisition by Aya Healthcare.

Cross Country Healthcare's Q1 2025 results show a revenue decline due to decreased demand in nurse and allied staffing, partially offset by growth in homecare and physician staffing, as the company progresses towards its merger with Aya Healthcare.

Cross Country Healthcare's Q3 2024 revenue decreased by 28.8% year-over-year, primarily due to declines in travel nurse and allied staffing, while physician staffing saw growth.

Cross Country Healthcare's Q2 2024 revenue decreased by 37% year-over-year, primarily due to reduced demand and lower bill rates in the Nurse and Allied Staffing segment.

Cross Country Healthcare files an amendment to its 2024 Annual Report to include detailed information on directors, executive officers, corporate governance, and executive compensation.

Cross Country Healthcare reports a 33.5% revenue decrease for 2024, impacted by declining travel nurse and allied staffing, while awaiting regulatory approval for its merger with Aya Healthcare.

Cross Country Healthcare's 2023 revenue declined by 28% due to normalization in travel nurse staffing, though the company saw growth in other segments.

Marvin Veizaga, Chief Accounting Officer of Cross Country Healthcare Inc, reported multiple transactions in common stock on July 21, 2026.

Amiee Lin Hawkins, Chief Operating Officer of Cross Country Healthcare Inc, reported multiple transactions in common stock on July 21, 2026.

Marc S. Krug, Group President, Delivery of Cross Country Healthcare Inc, reported multiple transactions in common stock on July 21, 2026.

Susan E Ball, General Counsel and Secretary of Cross Country Healthcare Inc, reported multiple transactions in common stock on July 21, 2026.

William J. Burns, Chief Financial Officer of Cross Country Healthcare Inc, reported multiple transactions in common stock on July 21, 2026.

Kevin Cronin Clark, Chief Executive Officer and a Director of Cross Country Healthcare Inc, reported multiple transactions in common stock on July 21, 2026.

Cross Country Healthcare, Inc. has filed a definitive proxy statement with the SEC under Section 14(a) of the Securities Exchange Act of 1934.

Cross Country Healthcare reports $1.3 billion revenue in 2024, maintains strong balance sheet, and anticipates Q4 2025 merger close with Aya Healthcare amidst industry challenges.

Cross Country Healthcare's merger with Aya Healthcare is now expected to close in the second half of 2025 due to a second request for information from the FTC.

Cross Country Healthcare is set to be acquired by Aya Healthcare in a deal valued at $615 million, offering stockholders $18.61 per share in cash.

Cross Country Healthcare has agreed to be acquired by Aya Healthcare, marking a significant milestone in its 40-year history.

Aya Healthcare will acquire Cross Country Healthcare for $18.61 per share in cash, valuing the transaction at approximately $615 million.

Magnetar Financial and affiliated entities have reduced their beneficial ownership in Cross Country Healthcare, Inc. to 4.98% after selling 183,678 shares.

Magnetar Financial and its affiliates have reduced their beneficial ownership in Cross Country Healthcare to 5.54% following the termination of the company's merger agreement with Aya Holdings II Inc.

Magnetar Financial LLC and its affiliates have increased their beneficial ownership in Cross Country Healthcare, Inc. to 7.20% of outstanding common stock through recent share purchases.

Magnetar Financial LLC and its affiliates have increased their beneficial ownership in Cross Country Healthcare, Inc. to 7.20% of outstanding common stock through recent share purchases.

Boston Partners has disclosed a significant passive ownership stake of 7.85% in Cross Country Healthcare Inc., representing over 2.5 million shares.

Dimensional Fund Advisors LP has disclosed a beneficial ownership of 1,609,925 shares, representing 5.0% of the outstanding common stock of Cross Country Healthcare Inc.

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Cross Country Healthcare Inc. following an internal realignment.

AllianceBernstein L.P. has reported a 5.9% beneficial ownership stake in Cross Country Healthcare Inc., held for investment purposes.

Goldman Sachs Group and its affiliate have filed an amended Schedule 13G, disclosing a 3.9% beneficial ownership stake in Cross Country Healthcare, Inc.

Goldman Sachs Group and its affiliate updated their beneficial ownership in Cross Country Healthcare, Inc., reporting a 5.8% stake.